Position in REPL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$685,607
-$2,154,430 QoQ
Shares Held
89,622
-69.3% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Derivatives in REPL
reported options exposure · as of Mar 31, 2026CallValue
$1,874,250
CallShares
245,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $1,494,072,071 across 362 Biotechnology names. REPL ranks #125 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
663,263 | $296,173,457 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
313,093 | $241,908,173 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
220,623 | $72,997,531 | |
| 4 | MRNA |
Moderna, Inc.
|
932,269 | $47,359,264 | |
| 5 | INSM |
INSMED Inc
|
275,731 | $45,087,531 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
1,415,848 | $39,218,988 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
383,179 | $37,264,156 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
669,601 | $35,301,364 |
All Filings in REPL
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $685,607 | 89,622 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $1,874,250 | 245,000 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $2,840,037 | 292,185 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $155,030 | 37,000 | Call | Sole | 2026-03-31 | |
| 2025-09-30 | $1,910,061 | 455,862 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $3,456,900 | 372,110 | Shares | Sole | 2026-02-27 | |
| 2025-06-30 | $705,111 | 75,900 | Call | Sole | 2026-02-27 | |
| 2025-03-31 | $1,509,260 | 154,796 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $2,026,353 | 167,329 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $1,737,061 | 158,491 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $537,300 | 59,700 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $886,689 | 108,530 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $2,448,948 | 290,504 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $2,026,029 | 118,412 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $2,624,115 | 113,011 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $1,616,401 | 91,529 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $1,309,516 | 48,144 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $857,852 | 49,673 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $31,918 | 1,826 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $89,161 | 5,251 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,185,624 | 43,750 | Shares | Sole | 2022-02-23 | |
| 2021-09-30 | $1,391,745 | 46,955 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $2,350,956 | 61,191 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,556,737 | 83,800 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $329,348 | 8,633 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $219,841 | 9,550 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $272,131 | 10,951 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $140,756 | 14,118 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||